SCHEMBL12729976

SCHEMBL12729976

CCCCC(C)C(=O)OCC(CO)CO

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.46
▸ TSHR P16473 3/20 0.46
▸ ATM Q13315 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ ALDH1A1 P00352 4/20 0.45
▸ CA2 P00918 2/20 0.44
▸ RECQL P46063 1/20 0.42
▸ CA1 P00915 3/20 0.41
▸ LMNA P02545 4/20 0.41
▸ MAPK1 P28482 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ PRSS1 P07477 1/20 0.39
▸ PRSS2 P07478 1/20 0.39
▸ PRSS3 P35030 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ DUSP3 P51452 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12729838 0.89 ALDH1A1 (0.42) CYP3A4TSHRATMTDP1ALDH1A1
SCHEMBL7218980 0.85 CYP3A4 (0.64) CYP3A4TSHRATMTDP1ALDH1A1
SCHEMBL30019360 0.84 KDM4E (0.56) CYP3A4TSHRATMTDP1CA2
SCHEMBL7224114 0.82 CA1 (0.45) CYP3A4TSHRATMTDP1ALDH1A1
SCHEMBL12729856 0.82 TSHR (0.44) CYP3A4TSHRATMTDP1ALDH1A1
SCHEMBL7629758 0.82 CYP3A4 (0.60) CYP3A4TSHRATMTDP1ALDH1A1
SCHEMBL7217028 0.82 CYP3A4 (0.60) CYP3A4TSHRATMTDP1ALDH1A1
SCHEMBL23926545 0.81 PRSS1 (0.53) CYP3A4TSHRATMTDP1ALDH1A1
SCHEMBL23926544 0.81 PRSS1 (0.53) CYP3A4TSHRATMTDP1ALDH1A1
SCHEMBL23926555 0.81 PRSS1 (0.53) CYP3A4TSHRATMTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110082210-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2011-04-07 — — US disclosed
US-20110082192-A1 LIPOIC ACID ACYLATED SALICYLATE DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2011-04-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110082210-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES FABP1, PPARA, FABP4 CYP3A4 432/4885TSHR 1281/4885ATM 3415/4885
US-20110082192-A1 LIPOIC ACID ACYLATED SALICYLATE DERIVATIVES AND THEIR USES ACACA, ACAT2, ACACB CYP3A4 2616/4885TSHR 3248/4885ATM 2126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback